✦ LIBER ✦

Subtelomeric 6p deletion: Clinical and array-CGH characterization in two patients

✍ Scribed by Danielle Martinet; Isabel Filges; Nathalie Besuchet Schmutz; Michael A. Morris; Anne-Claude Gaide; Sophie Dahoun; Armand Bottani; Marie-Claude Addor; Stylianos E. Antonarakis; Jacques S. Beckmann; Frédérique Béna

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 227 KB
Volume: 146A
Category: Article
ISSN: 1552-4825
DOI: 10.1002/ajmg.a.32414

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subtelomeric 6p deletion: Clinical, FISH

Subtelomeric 6p deletion: Clinical, FISH, and array CGH characterization of two cases

✍ Cédric Le Caignec; Philippe De Mas; Marie-Claire Vincent; Michelle Bocéno; Georg 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 1 views

Array-CGH and clinical characterization

Array-CGH and clinical characterization in a patient with subtelomeric 6p deletion without ocular dysgenesis

✍ Maria Piccione; R. Antona; E. Salzano; S. Cavani; M. Malacarne; R. Morreale Bube 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB 👁 1 views

## Abstract Subtelomeric terminal 6p deletion has been recognized as a clinically identifiable syndrome including facial dysmorphism, malformation of the anterior eye chamber, hearing loss, heart defects, and developmental delay. Genotype–phenotype correlations of previously published patients have

Investigation of 4q-deletion in two unre

Investigation of 4q-deletion in two unrelated patients using array CGH

✍ S.S. Kaalund; R.S. Møller; A. Tészás; M. Miranda; G. Kosztolanyi; R. Ullmann; N. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

The clinical utility of enhanced subtelo

The clinical utility of enhanced subtelomeric coverage in array CGH

✍ Blake C. Ballif; Scott G. Sulpizio; Richard M. Lloyd; Sara L. Minier; Aaron Thei 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB 👁 1 views

Clinical and molecular characterization

Clinical and molecular characterization of a patient with a 2q31.2-32.3 deletion identified by array-CGH

✍ Maria Antonietta Mencarelli; Rossella Caselli; Chiara Pescucci; Giuseppe Hayek; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB 👁 1 views

Cytogenetic and array-CGH characterizati

Cytogenetic and array-CGH characterization of a 6q27 deletion in a patient with developmental delay and features of Ehlers–Danlos syndrome

✍ A.L. Mosca; P. Callier; A. Masurel-Paulet; C. Thauvin-Robinet; N. Marle; M. Nouc 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views